Normalized volume of interest selection and measurement of bone volume in MicroCT scans

Bone

Volumn 49, Issue 6, 2011, Pages 1264-1269

  Snoeks, T J A ^a   Kaijzel, E L ^a   Que, I ^a   Mol, I M ^a   Lowik C W G M ^a   Dijkstra, J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Imaging; Metastatic bone disease; Micro CT; Osteolysis; Quantification; Radiography; Volume measurements

Indexed keywords

ANALYTIC METHOD; ANALYTICAL ERROR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DIAMETER; BONE DISEASE; BONE LESION; BONE MASS; BONE STRUCTURE; CONTROLLED STUDY; DISLOCATION; FEMALE; FRACTURE; IMAGE ANALYSIS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; NORMALIZED VOLUME OF INTEREST SELECTION; OSTEOLYSIS;

ANIMALS; BONE AND BONES; CELL LINE, TUMOR; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICE, INBRED BALB C; ORGAN SIZE; OSTEOLYSIS; X-RAY MICROTOMOGRAPHY;

EID: 81355146655     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.09.037     Document Type: Article

References (15)

1. Abrams H.L., Spiro R., Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950, 3:74-85.
2. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2:584-593. [DOI:10.1038/nrc867] [PubMed:12154351].
3. Guise T.A., Mundy G.R. Cancer and bone. Endocr Rev 1998, 19:18-54.
4. Clines G.A., Guise T.A. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 2005, 12:549-583. [DOI:10.1677/erc.1.00543] [PubMed:16172192].
5. Nakai M., Mundy G.R., Williams P.J., Boyce B., Yoneda T. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res 1992, 52:5395-5399.
6. Sasaki A., Boyce B.F., Story B., Wright K.R., Chapman M., Boyce R., et al. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 1995, 55:3551-3557.
7. Peyruchaud O., Winding B., Pecheur I., Serre C.M., Delmas P., Clezardin P. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions. J Bone Miner Res 2001, 16:2027-2034. [DOI:10.1359/jbmr.2001.16.11.2027] [PubMed:11697798].
8. Wetterwald A., van der Pluijm G., Que I., Sijmons B., Buijs J., Karperien M., et al. Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 2002, 160:1143-1153. [PubMed Central:PMC1867183] [PubMed:11891210].
9. Arguello F., Baggs R.B., Frantz C.N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988, 48:6876-6881.
10. Patt H.M., Maloney M.A. Bone marrow regeneration after local injury: a review. Exp Hematol 1975, 3:135-148.
11. Bab I., Gazit D., Muhlrad A., Shteyer A. Regenerating bone marrow produces a potent growth-promoting activity to osteogenic cells. Endocrinology 1988, 123:345-352.
12. Boucharaba A., Serre C.M., Gres S., Saulnier-Blache J.S., Bordet J.C., Guglielmi J., et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 2004, 114:1714-1725. [PubMed Central:PMC535068] [DOI:10.1172/JCI22123] [PubMed:15599396].
13. Buijs J.T., Que I., Lowik C.W., Papapoulos S.E., van der Pluijm G. Inhibition of bone resorption and growth of breast cancer in the bone microenvironment. Bone 2009, 44:380-386. [DOI:10.1016/j.bone.2008.10.047] [PubMed:19041433].
14. van der Pluijm G., Que I., Sijmons B., Buijs J.T., Lowik C.W., Wetterwald A., et al. Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo. Cancer Res 2005, 65:7682-7690. [DOI:10.1158/0008-5472.CAN-04-4188] [PubMed:16140935].
15. Johnson L.C., Johnson R.W., Munoz S.A., Mundy G.R., Peterson T.E., Sterling J.A. Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction. Bone 2011, 48:141-151. [PubMed Central:PMC2974944] [DOI:10.1016/j.bone.2010.05.033] [PubMed:20685406].